Dawnrays Pharmaceutical (Holdings) Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dawnrays Pharmaceutical (Holdings) Ltd with three other
companies in this sector in Hong Kong:
Beijing Tong Ren Tang Chinese Medicine Company Limited
sales of 970.48 million Hong Kong Dollars [US$125.08 million]
of which 76%
was Healthcare products and Chinese medicine),
Jacobson Pharma Corporation Ltd
(947.59 million Hong Kong Dollars [US$122.13 million]
of which 89%
was Generic drugs), and
Consun Pharmaceutical Group Ltd
(1.02 billion Hong Kong Dollars [US$132.05 million]
of which 100%
was Manufacturing and sales of pharmaceutica).
During the year ended December of 2015, sales at
Dawnrays Pharmaceutical (Holdings) Ltd were HK$1.21 billion (US$156.50 million).
increase of 23.3%
versus 2014, when the company's sales were HK$985.13 million.
Sales of Intermediates and Bulk Medicines saw an increase
that was more than double the company's growth rate: sales were up
56.6% in 2015, from
HK$188.57 million to HK$295.39 million.